Peter Teismann

9.6k total citations · 3 hit papers
60 papers, 7.7k citations indexed

About

Peter Teismann is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Peter Teismann has authored 60 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 28 papers in Cellular and Molecular Neuroscience and 20 papers in Molecular Biology. Recurrent topics in Peter Teismann's work include Parkinson's Disease Mechanisms and Treatments (30 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Genetic Neurodegenerative Diseases (10 papers). Peter Teismann is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (30 papers), Neuroinflammation and Neurodegeneration Mechanisms (14 papers) and Genetic Neurodegenerative Diseases (10 papers). Peter Teismann collaborates with scholars based in Germany, United States and United Kingdom. Peter Teismann's co-authors include Serge Przedborski, Miquel Vila, Kim Tieu, Vernice Jackson‐Lewis, Dong‐Kug Choi, Boris Ferger, Jörg B. Schulz, Du‐Chu Wu, Harry Ischiropoulos and Heather L. Martin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Peter Teismann

60 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

2002 1.0k citations Du Chu Wu, Vernice Jackson‐Lewis et al. Journal of Neuroscience profile →
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

2003 546 citations Peter Teismann, Kim Tieu et al. profile →
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

2003 510 citations Du‐Chu Wu, Peter Teismann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Teismann Germany	39	3.2k	2.6k	2.6k	2.5k	1.7k	60	7.7k
Luis Barbeito Uruguay	47	2.3k 0.7×	1.9k 0.7×	2.7k 1.0×	1.3k 0.5×	1.8k 1.1×	112	6.6k
Stéphane Hunot France	39	5.1k 1.6×	4.3k 1.6×	3.8k 1.5×	4.2k 1.6×	2.0k 1.2×	59	11.6k
Noel Y. Calingasan United States	54	2.1k 0.7×	1.9k 0.7×	4.5k 1.7×	1.1k 0.4×	2.2k 1.3×	111	8.3k
Magdalena Sastre United Kingdom	51	1.2k 0.4×	2.3k 0.9×	3.8k 1.4×	2.6k 1.0×	4.2k 2.5×	99	9.1k
Ranjita Betarbet United States	29	4.6k 1.4×	3.7k 1.4×	2.9k 1.1×	1.6k 0.6×	1.3k 0.8×	46	8.3k
Donato A. Di Monte United States	67	7.2k 2.3×	5.1k 1.9×	3.7k 1.4×	2.1k 0.9×	2.7k 1.6×	167	13.7k
Masato Asanuma Japan	45	1.5k 0.5×	2.3k 0.9×	2.1k 0.8×	1.2k 0.5×	868 0.5×	235	6.7k
Céline Perier Spain	33	3.5k 1.1×	2.2k 0.8×	2.6k 1.0×	950 0.4×	1.8k 1.1×	41	6.7k
Lichuan Yang United States	51	3.5k 1.1×	4.0k 1.5×	6.3k 2.4×	1.3k 0.5×	2.1k 1.3×	79	10.7k
Teresa G. Hastings United States	41	3.0k 0.9×	3.2k 1.2×	2.7k 1.0×	918 0.4×	1.2k 0.7×	54	7.2k

Countries citing papers authored by Peter Teismann

Since Specialization

Citations

This map shows the geographic impact of Peter Teismann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Teismann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Teismann more than expected).

Fields of papers citing papers by Peter Teismann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Teismann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Teismann. The network helps show where Peter Teismann may publish in the future.

Co-authorship network of co-authors of Peter Teismann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Teismann. A scholar is included among the top collaborators of Peter Teismann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Teismann. Peter Teismann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mounsey, Ross B., Sarah Mustafa, Lianne Robinson, et al.. (2015). Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Experimental Neurology. 273. 36–44. 56 indexed citations

2.

Perier, Céline, Andreas Bender, Elena García‐Arumí, et al.. (2013). Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Brain. 136(8). 2369–2378. 58 indexed citations

3.

Hübener‐Schmid, Jeannette, Nicolas Casadei, Peter Teismann, et al.. (2012). Automated Behavioral Phenotyping Reveals Presymptomatic Alterations in a SCA3 Genetrap Mouse Model. Journal of genetics and genomics. 39(6). 287–299. 12 indexed citations

4.

Maetzler, Walter, Johannes Lang, Ross B. Mounsey, et al.. (2012). S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway. Brain. 135(11). 3336–3347. 170 indexed citations

5.

Teismann, Peter. (2012). COX‐2 in the neurodegenerative process of Parkinson's disease. BioFactors. 38(6). 395–397. 76 indexed citations

6.

Nuber, Silke, Elisabeth Petrasch‐Parwez, Óscar Arias-Carrión, et al.. (2011). Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiology of Disease. 44(2). 192–204. 23 indexed citations

7.

Hsieh, Ya‐Ching, Ross B. Mounsey, & Peter Teismann. (2011). MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(2). 157–167. 27 indexed citations

8.

Moisoi, Nicoleta, Kristina Klupsch, Valentina Fedele, et al.. (2008). Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death and Differentiation. 16(3). 449–464. 143 indexed citations

9.

Meuer, Katrin, Claudia Pitzer, Peter Teismann, et al.. (2006). Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's disease. Journal of Neurochemistry. 97(3). 675–686. 103 indexed citations

10.

Choi, Dong‐Kug, Subramaniam Pennathur, Céline Perier, et al.. (2005). Ablation of the Inflammatory Enzyme Myeloperoxidase Mitigates Features of Parkinson's Disease in Mice. Journal of Neuroscience. 25(28). 6594–6600. 238 indexed citations

11.

Martins, L. Miguel, Alastair Morrison, Kristina Klupsch, et al.. (2004). Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice. Molecular and Cellular Biology. 24(22). 9848–9862. 315 indexed citations

12.

Teismann, Peter & Jörg B. Schulz. (2004). Cellular pathology of Parkinson?s disease: astrocytes, microglia and inflammation. Cell and Tissue Research. 318(1). 149–161. 303 indexed citations

13.

Tieu, Kim, Céline Perier, Casper Caspersen, et al.. (2003). D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. Journal of Clinical Investigation. 112(6). 892–901. 357 indexed citations

14.

Przedborski, Serge, Vernice Jackson‐Lewis, Miquel Vila, et al.. (2003). Free radical and nitric oxide toxicity in Parkinson's disease.. PubMed. 91. 83–94. 30 indexed citations

15.

Kuner, Rohini, Peter Teismann, Angelika Richter, et al.. (2003). TorsinA, the gene linked to early-onset dystonia, is upregulated by the dopaminergic toxin MPTP in mice. Neuroscience Letters. 355(1-2). 126–130. 19 indexed citations

16.

Tieu, Kim, Céline Perier, Casper Caspersen, et al.. (2003). D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. Journal of Clinical Investigation. 112(6). 892–901. 349 indexed citations

17.

Guégan, Christelle, Peter Teismann, Ali Naini, et al.. (2001). Increased expression of the pro‐inflammatory enzyme cyclooxygenase‐2 in amyotrophic lateral sclerosis. Annals of Neurology. 49(2). 176–185. 15 indexed citations

18.

Xia, Xu, Nicole Schmidt, Peter Teismann, Boris Ferger, & Jörg B. Schulz. (2001). Dopamine mediates striatal malonate toxicity via dopamine transporter‐dependent generation of reactive oxygen species and D2 but not D1 receptor activation. Journal of Neurochemistry. 79(1). 63–70. 43 indexed citations

19.

Teismann, Peter & Boris Ferger. (2000). Effects of ensaculin on dopamine metabolite levels and K+-induced glutamate release. European Journal of Pharmacology. 398(2). 247–250. 7 indexed citations

20.

Ferger, Boris, et al.. (1998). Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(3). 351–359. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact